PubMed Health⌕ Search

PubMed · 12479276

Using Bayes' theorem to answer a practical heart valve question.

Abstract

BACKGROUND AND AIM OF THE STUDY: The risk of thromboembolism (TE) risk in a heart valve patient who has lived perhaps for 15 years since implant without TE or thrombosis is unknown. As patients are heterogeneous with regard to embolic risk, these patients must have a lower than average risk; whether this risk reduction could be quantified was the aim of the present study. METHODS: If all patients had the same risk, the TE-free curve would be exponential, with a constant hazard (equal to the 'linearized' rate). With a mixture of risks in a population, the population hazard will be a decreasing function of time. By fitting a certain parametric function to the TE-free curve, the mixing distribution can be estimated. Subsequently, given an observation for a particular patient, e.g. zero emboli in 15 years, Bayes' theorem can be used to update the mixing distribution for these patients. RESULTS: Using observed TE-free curves for Starr-Edwards valves, the mixing distribution for TE-free periods from one to 25 years was estimated. Because the risk distributions were skewed, the mean value was higher than the median. The mean (median) risk (% per year) fell from 4.5 (1.8) at implant to 1.7 (0.7) at 15 years for the aortic position, and from 7.0 (3.4) to 2.4 (1.2) for the mitral position. Thus, the average risk after 15 years was approximately 35-40% of the risk at implant for both the aortic and mitral positions, using either the mean or median risk. CONCLUSION: The mean risk for patients after 15 TE-free years is approximately one-third of the risk of all patients at implant. However, there is a wide range, with some patients still having higher risks. Bayes' theorem is useful for deriving such answers. Linearized rates have limited value for describing TE risk in a heterogeneous population.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Gary L Grunkemeier. 2002. Using Bayes' theorem to answer a practical heart valve question.. https://pubmed.ncbi.nlm.nih.gov/12479276/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Right-sided vegetation unmasks aortic endocarditis.

Echocardiography is a key tool in the diagnosis of infective endocarditis. Although transthoracic echocardiography is the first step in the work-up, transoesophageal echocardiography is mandatory for the evaluation of the exact extent of the infectious process. Indeed, perivalvular abscess can fistulate towards different heart chambers, leading sometimes to critical clinical situations.

Aortic Valve↗

Aortic translocation for the management of transposition of the great arteries with a ventricular septal defect, pulmonary stenosis, and hypoplasia of the right ventricle.

A 2-month-old patient with transposition of the great arteries, a ventricular septal defect, pulmonary stenosis, and severe hypoplasia of the right ventricle successfully underwent a biventricular repair utilizing the aortic translocation technique. Advantages of this surgical repair over the Rastelli procedure in the management of this complex congenital heart lesion are discussed.

Aortic Valve↗

Evidence in favor of linkage to human chromosomal regions 18q, 5q and 13q for bicuspid aortic valve and associated cardiovascular malformations.

The aim of this study was to identify regions of the genome that harbor genes influencing inheritance of bicuspid aortic valve (BAV) and/or associated cardiovascular malformation (CVM). Aortic valve disease is an important clinical problem, which often results in valve replacement, the second most common cardiac surgery in the United States. In every age group, a majority of cases of valve disease involves a BAV. BAV is the most common CVM with a reported prevalence of 1-2%. Heritability studies indicate that BAV determination is almost entirely genetic. We used a family-based genome-wide linkage analysis with microsatellite markers. Parametric and nonparametric analyses were performed with the software GENEHUNTER and SOLAR (Sequential Oligogenic Linkage Analysis Routines). Thirty-eight families (353 subjects) with BAV and/or associated CVM were assessed. Each participant underwent a standardized echocardiographic examination. The highest LOD score, 3.8, occurred on chromosome 18q between markers D18S68 and D18S1161. Two other chromosomal regions, 5q15-21 (between D5S644 and D5S2027) and 13q33-qter (between D13S1265 and 13qter), exhibited suggestive evidence of linkage (LOD > 2.0). Further, two previously reported linkage peaks on 9q34 and 17q24 were replicated in family specific analyses. No significant X chromosome linkage peaks were identified. In this genome-wide scan we demonstrate for the first time, that BAV and/or associated CVM exhibit linkage to chromosomes 18q, 5q and 13q. These regions likely contain genes whose mutation results in BAV and/or associated CVM indicating their important role in valvulogenesis and cardiac development.

Aortic Valve↗